Item

Clinical Trials for HIV Vaccine has been Overwhelming Success due to the help of COVID-19 Vaccine

Title (Dublin Core)

Clinical Trials for HIV Vaccine has been Overwhelming Success due to the help of COVID-19 Vaccine

Description (Dublin Core)

Clinical trials for HIV vaccines have been overwhelmingly successful with a 97% success rate at stimulating the production of rare immune cells which could lead to vaccines in the future. The COVID-19 vaccine has led to the increased development of m-RNA dosed vaccine which is also found in many other vaccines. By producing the COVID-19 vaccine has led to much more funding and research into the mRNA vaccine field which will bring about new changes in medicine in the future.

Date (Dublin Core)

April 9, 2021

Creator (Dublin Core)

Juwan J. Holmes

Contributor (Dublin Core)

Robert Baker-Nicholas

Event Identifier (Dublin Core)

HST580

Partner (Dublin Core)

Arizona State University

Type (Dublin Core)

Text Story

Link (Bibliographic Ontology)

https://www.lgbtqnation.com/2021/04/clinical-trial-hiv-vaccine-overwhelming-success/
https://www.lgbtqnation.com/2021/04/clinical-trial-hiv-vaccine-overwhelming-success/
https://web.archive.org/web/20210425185512/https://www.facebook.com/photo?fbid=491097285362829&set=gm.1127165214361148

Controlled Vocabulary (Dublin Core)

English Gender & Sexuality
English Healthcare
English Technology

Curator's Tags (Omeka Classic)

HIV
vaccine
mRNA
medicine
success
Moderna
LGBTQIA+

Contributor's Tags (a true folksonomy) (Friend of a Friend)

HIV
vaccine
COVID-19
Moderna
m-RNA
research
LGBTQ

Collection (Dublin Core)

LGBTQ+
Vaccine Stories

Linked Data (Dublin Core)

HST 580 Professional Experience/Archives course

Date Submitted (Dublin Core)

04/18/2021

Date Modified (Dublin Core)

04/25/2021
09/05/2021
08/02/2022

Item sets

Covid 19

This item was submitted on April 18, 2021 by Robert Baker-Nicholas using the form “Share Your Story” on the site “A Journal of the Plague Year”: https://www.covid-19archive.org/s/archive

Click here to view the collected data.

New Tags

I recognize that my tagging suggestions may be rejected by site curators. I agree with terms of use and I accept to free my contribution under the licence CC BY-SA.